Wavemaker Three-Sixty Health

Wavemaker Three-Sixty Health appears to be the same firm as Wavemaker 360 Health, with identical website (wavemaker360.com), LinkedIn handle, Twitter handle, and Crunchbase profile, suggesting this is a duplicate or alternate spelling of the same investor. Treating it as the same firm, the analysis is consistent: a US-based healthcare-focused early-stage venture firm explicitly oriented to digital health and healthcare technology investments. For healthcare AI founders, the same recommendation applies: Wavemaker Three-Sixty Health is a credible primary lead candidate for seed and Series A rounds in AI-driven clinical decision support, ambient documentation, payer automation, behavioral health technology, and care coordination platforms with early traction and credible founding teams. Pure biotech, drug discovery, and capital-intensive medical devices are not the firm’s stated focus. Check sizes typically span USD 1M to USD 5M at seed and Series A with selective follow-on, and the US geographic anchor with selective international healthcare deal flow remains the same. Best entry path is a warm introduction through a Wavemaker portfolio CEO, a healthcare ecosystem connector, or a US digital health banker, supplemented by direct outreach via LinkedIn or the website. Founders should be aware that engaging this firm twice through the duplicate slug will not change outcomes; pick one identifier and run a single, well-prepared process. Bring real clinical evidence, payer or provider commercial proof points, and a clear regulatory strategy to the first meeting, just as you would for the primary listing. Healthcare-fluent founders with credible traction will find a serious partner; generalist software pitches without sector depth will not.